Cargando…
Clinical, imaging, and biomarker evidence of amyloid- and tau-related neurodegeneration in late-onset epilepsy of unknown etiology
Accumulating evidence suggests amyloid and tau-related neurodegeneration may play a role in development of late-onset epilepsy of unknown etiology (LOEU). In this article, we review recent evidence that epilepsy may be an initial manifestation of an amyloidopathy or tauopathy that precedes developme...
Autores principales: | Hickman, L. Brian, Stern, John M., Silverman, Daniel H. S., Salamon, Noriko, Vossel, Keith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565489/ https://www.ncbi.nlm.nih.gov/pubmed/37830092 http://dx.doi.org/10.3389/fneur.2023.1241638 |
Ejemplares similares
-
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics
por: Nardi Cesarini, Elena, et al.
Publicado: (2020) -
Late-onset seizures and epilepsy: Electroclinical features suggestive of autoimmune etiology
por: Morano, Alessandra, et al.
Publicado: (2022) -
High frequency of cerebrospinal fluid autoantibodies in patients with seizures or epilepsies of unknown etiology
por: Schulz, Paulina, et al.
Publicado: (2023) -
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy
por: DiFrancesco, Jacopo C., et al.
Publicado: (2022) -
Late-Onset Focal Epilepsy: Electroclinical Features and Prognostic Role of Leukoaraiosis
por: Tartara, Elena, et al.
Publicado: (2022)